Parvez Mantry
Methodist Dallas Medical Center(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, Hepatocellular Carcinoma Treatment and Prognosis, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial(2017)544 cited
- → An Interferon-free Antiviral Regimen for HCV after Liver Transplantation(2014)402 cited
- → Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease(2016)277 cited
- → Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis(2017)227 cited
- → Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib(2018)202 cited
- → Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma(2019)187 cited
- → Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection(2018)179 cited
- → Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study(2019)161 cited
- → Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy(2013)158 cited
- → Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma(2007)156 cited